KAHR Bio: Pioneering Immunotherapeutics for Advanced Cancer Treatment.
No named decision-maker yet.
No careers mailbox known
Sep 2026
Formerly KAHR Bio (kahrbio.com)
Sep 28
Moved to
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatment of serious diseases with significant unmet medical needs in the orphan drug segment.
No named decision-maker yet.
Careers mailbox is known
2018
Founded
Lipum is a biopharmaceutical company specialized on a novel way to treat chronic inflammatory diseases.
Scientific Advisory · Directors · decision-maker
Careers mailbox is known
Apr 20, 2021
Raised a round Venture round $8.1M · Mynewsdesk
About Microbiotica is a leading, clinical stage biopharmaceutical company specialising in the development of precision live biotherapeutic products (LBPs) with lead products in immuno-oncology and inflammatory bowel disease.
Scientific Advisors Investors · Directors · decision-maker
Careers mailbox is known
May 6, 2025
Launched Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal bar… · The Manila Times
2021
Founded
